Anne Goriely

Prof. Anne Goriely


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2018 in Cell Research
Verified
Journal Article
Open access
PDF file
JGJingtao Guo
Jingtao Guo
EGEdward J. Grow
Edward J. Grow
HMHana Mlcochova
Hana Mlcochova
GMGeoffrey J. Maher
Geoffrey J. Maher
CLCecilia Lindskog
Cecilia Lindskog
BCBradley R. Cairns
Bradley R. Cairns
Human adult spermatogenesis balances spermatogonial stem cell (SSC) self-renewal and differentiation, alongside complex germ cell-niche interactions, to ensure long-term fertility and faithful genome propagation. Here, we performed single-cell RNA sequencing of ~6500 testicular cells from young adults. We found five niche/somatic cell types (Leydig, myoid, Sertoli, endothelial, macrophage), and observed germline-niche interactions and key human-mouse differences. Spermatogenesis, including meiosis, was reconstructed computationally, revealing sequential coding, non-coding, and repeat-element transcriptional signatures. Interestingly, we identified five discrete transcriptional/developmental spermatogonial states, including a novel early SSC state, termed State 0. Epigenetic features and nascent transcription analyses suggested developmental plasticity within spermatogonial States. To understand the origin of State 0, we profiled testicular cells from infants, and identified distinct similarities between adult State 0 and infant SSCs. Overall, our datasets describe key transcriptional and epigenetic signatures of the normal adult human testis, and provide new insights into germ cell developmental transitions and plasticity.

1 September 2003 in Neuron
Verified
Journal Article
Closed access
RCRuth Diez Del Corral
Ruth Diez Del Corral
IOIsabel Olivera-Martinez
Isabel Olivera-Martinez
AGAnne Goriely
Anne Goriely
EGEmily Gale
Emily Gale
MMMalcolm Maden
Malcolm Maden
KSKate Storey
Kate Storey

18 May 2015 in Nature Genetics
Verified
Journal Article
Open access
PDF file
JTJenny Taylor
Jenny Taylor
HMHilary C Martin
Hilary C Martin
SLStefano Lise
Stefano Lise
JBJohn Broxholme
John Broxholme
JCJean-Baptiste Cazier
Jean-Baptiste Cazier
GMGilean McVean
Gilean McVean
Gilean McVean and colleagues report the results of a large-scale clinical genome sequencing project spanning a broad spectrum of disorders. They identify factors influencing successful genetic diagnosis and highlight the challenges of interpreting findings for genetically heterogeneous disorders. To assess factors influencing the success of whole-genome sequencing for mainstream clinical diagnosis, we sequenced 217 individuals from 156 independent cases or families across a broad spectrum of disorders in whom previous screening had identified no pathogenic variants. We quantified the number of candidate variants identified using different strategies for variant calling, filtering, annotation and prioritization. We found that jointly calling variants across samples, filtering against both local and external databases, deploying multiple annotation tools and using familial transmission above biological plausibility contributed to accuracy. Overall, we identified disease-causing variants in 21% of cases, with the proportion increasing to 34% (23/68) for mendelian disorders and 57% (8/14) in family trios. We also discovered 32 potentially clinically actionable variants in 18 genes unrelated to the referral disorder, although only 4 were ultimately considered reportable. Our results demonstrate the value of genome sequencing for routine clinical diagnosis but also highlight many outstanding challenges.

1 February 2012 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
AGAnne Goriely
Anne Goriely
AWAndrew O. M. Wilkie
Andrew O. M. Wilkie

1 October 2017 in Cell Stem Cell
Verified
Journal Article
Open access
JGJingtao Guo
Jingtao Guo
EGEdward J. Grow
Edward J. Grow
CYChongil Yi
Chongil Yi
HMHana Mlcochova
Hana Mlcochova
GMGeoffrey J. Maher
Geoffrey J. Maher
BCBradley R. Cairns
Bradley R. Cairns
Human adult spermatogonial stem cells (hSSCs) must balance self-renewal and differentiation. To understand how this is achieved, we profiled DNA methylation and open chromatin (ATAC-seq) in SSEA4+ hSSCs, analyzed bulk and single-cell RNA transcriptomes (RNA-seq) in SSEA4+ hSSCs and differentiating c-KIT+ spermatogonia, and performed validation studies via immunofluorescence. First, DNA hypomethylation at embryonic developmental genes supports their epigenetic "poising" in hSSCs for future/embryonic expression, while core pluripotency genes (OCT4 and NANOG) were transcriptionally and epigenetically repressed. Interestingly, open chromatin in hSSCs was strikingly enriched in binding sites for pioneer factors (NFYA/B, DMRT1, and hormone receptors). Remarkably, single-cell RNA-seq clustering analysis identified four cellular/developmental states during hSSC differentiation, involving major transitions in cell-cycle and transcriptional regulators, splicing and signaling factors, and glucose/mitochondria regulators. Overall, our results outline the dynamic chromatin/transcription landscape operating in hSSCs and identify crucial molecular pathways that accompany the transition from quiescence to proliferation and differentiation.

1 August 2003 in Science
Verified
Journal Article
Closed access
PDF file
AGAnne Goriely
Anne Goriely
GMGilean A. T. McVean
Gilean A. T. McVean
MRMaria RöjMyr
Maria RöjMyr
BIBjörN Ingemarsson
BjörN Ingemarsson
AWAndrew O. M. Wilkie
Andrew O. M. Wilkie
Observed mutation rates in humans appear higher in male than female gametes and often increase with paternal age. This bias, usually attributed to the accumulation of replication errors or inefficient repair processes, has been difficult to study directly. Here, we describe a sensitive method to quantify substitutions at nucleotide 755 of the fibroblast growth factor receptor 2 ( FGFR2 ) gene in sperm. Although substitution levels increase with age, we show that even high levels originate from infrequent mutational events. We propose that these FGFR2 mutations, although harmful to embryonic development, are paradoxically enriched because they confer a selective advantage to the spermatogonial cells in which they arise.